Skip to main content
Caplight Logo









NuGenomics

NuGenomics

Private
BangaloreHealthcare & Life Scienceshttps://www.nugenomics.in/

Last Round

Early Funding

Oct 5, 2023

Total Funding Raised

$500,000

Company Overview

NuGenomics is a health-tech company that provides DNA-based genetic testing and personalized wellness plans for weight management, diabetes, and longevity.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Healthcare Analytics, Biotechnology, Sports & Fitness

Business Model

B2C

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingpersonalized healthbiohackingpreventive healthcareDNA testingprecision nutritionmetabolic analysiscorporate wellnesshealth-techlongevitydirect-to-consumerDTCAI healthblood diagnosticslifestyle coaching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NuGenomics Comparables

Compare NuGenomics with similar companies based on industry and business-model similarity.

NuGenomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Unlock.fit
91%
Gena HealthX
83%
Lifecode Genorex Pvt. Ltd.
82%

NuGenomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 5, 2023
AcceleratorJun 21, 2021

Key People

Founding team and executive leadership

Rahul Ranganathan

Chief Executive Officer

Executive Team

Balamurali A R

Chief Technology Officer

Executive Team

NuGenomics Investors

Notable investors and investment history

NuGenomics investors
InvestorRounds
India AcceleratorAccelerator
Inflection Point VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 469% MoM, reaching 16.7K.

  • Apr 5, 2026

    Monthly visitors grew 991% MoM, reaching 32.1K.

NuGenomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NuGenomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NuGenomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range14
Year Founded2019
Last FundingOct 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?